NULEXA

Medical diagnostic test media in the form of a cartridge for measuring , testing and analyzing blood and other bodily fluids for use in the detection of infectious diseases, including viral and bacterial pathogens; Diagnostic reagents for medical use in in vitro diagnosis; In vitro diagnostic preparations for medical use; In vitro diagnostic preparations for medical purposes; Medical diagnostic reagents and assays for testing of body fluids; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, viral and bacterial pathogens; Diagnostic kits comprised of medical diagnostic reagents and assays for testing of bodily fluids for use in disease detection, namely, Influenza A, Influenza B, SARS-CoV-2, Respiratory Syncytial Virus (RSV), and Group A Streptococcus (Strep A); Diagnostic kits comprising diagnostic agents, preparations and substances for medical purposes; Diagnostic kits comprising diagnostic agents, preparations and substances for medical use; Diagnostic test reagents for medical use; Diagnostic test reagents for medical purposes; Medical diagnostic reagents; Medical diagnostic reagents for the analysis of body fluids; Diagnostic chemical reagents for medical use; Diagnostic chemical reagents for medical purposes

Medical diagnostic apparatus for testing and analyzing blood and other bodily fluids; Medical diagnostic apparatus for testing for viruses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing; Sample preparation device for medical diagnostic uses; Medical diagnostic apparatus for testing blood and other bodily fluids incorporating recorded operating system software; Medical diagnostic apparatus for detecting viruses and bacteria with embedded operating Software in a Medical Device (SiMD); Medical diagnostic apparatus for detecting viruses and bacteria

Medical services, namely, medical molecular diagnostic, testing, monitoring, and reporting services; Medical services, namely, molecular research and development services